Wells Fargo & Company MN Has $2.57 Million Stake in Aspen Aerogels, Inc. (NYSE:ASPN)

Wells Fargo & Company MN increased its position in Aspen Aerogels, Inc. (NYSE:ASPN) by 158.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 216,049 shares of the construction company’s stock after buying an additional 132,489 shares during the period. Wells Fargo & Company MN owned 0.26% of Aspen Aerogels worth $2,567,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. AlphaQuest LLC raised its stake in shares of Aspen Aerogels by 54.0% in the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock valued at $135,000 after acquiring an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $164,000. Journey Strategic Wealth LLC acquired a new stake in shares of Aspen Aerogels in the fourth quarter worth $178,000. Ballentine Partners LLC boosted its holdings in shares of Aspen Aerogels by 19.2% during the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company’s stock worth $189,000 after buying an additional 2,565 shares during the period. Finally, Aigen Investment Management LP acquired a new position in Aspen Aerogels in the 4th quarter valued at $219,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Craig Hallum cut their target price on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, February 14th. Roth Mkm decreased their target price on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Friday, February 14th. TD Cowen raised Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, March 11th. B. Riley reduced their price objective on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a research report on Wednesday, February 19th. Finally, Canaccord Genuity Group dropped their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $19.11.

Aspen Aerogels Stock Performance

NYSE:ASPN opened at $5.45 on Friday. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The firm has a 50-day moving average price of $6.60 and a 200 day moving average price of $11.88. The firm has a market capitalization of $447.47 million, a PE ratio of 34.06 and a beta of 2.35. Aspen Aerogels, Inc. has a 12-month low of $4.80 and a 12-month high of $33.15.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. Research analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.